Company patents
Sight Sciences, Inc.
Sight Sciences, Inc. demonstrates a strong focus on Implants & Prosthetics, which constitutes 90.0% of its patent portfolio, showing consistent growth with a 28.6% increase in 2025, though patenting in this area has slowed so far in 2026. Surprisingly, despite its medical device core, the company also maintains a significant, albeit declining, interest in Pharmaceutical Preparations (24.0% of portfolio), which saw a 75.0% decline in patenting activity so far in 2026, indicating a potential shift away from pharma-related innovation.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
50 US filings (since 2023) · 6 categories · 5 themes
Integrated systems and specialized instruments for performing delicate surgical procedures on the eye, often involving the delivery, manipulation, or monitoring of ophthalmic implants.
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Implantable devices that deliver electrical, optical, or other forms of energy to stimulate tissues or nerves, or sense physiological parameters for therapeutic purposes.
Patents
Showing 1-2 of 2
Targeted Drug Formulation Delivery